FDA Inspection 1078045 — American Red Cross Blood Services Southwest Region

American Red Cross Blood Services Southwest Region — FEI 3006805687

The FDA completed an inspection of American Red Cross Blood Services Southwest Region on January 31, 2019 in Dallas, TX. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 31, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Dallas, TX (United States)

Citations

IDCFRDescription
6721 CFR 606.65(e)Following manufacturer's instructions